Tech

Until recently, the term “telehealth” was known in the medical community, but not the cannabis community.

Since the COVID-19 outbreak sent the country into lockdown, medical marijuana users in many states can now check in with a health care provider by video for authorization, rather than an in-person meeting.

According to MPP.org, 31 states currently allow telemedicine for cannabis patients – 11 of which have temporarily altered their laws as a result of the current coronavirus pandemic.

The issues surrounding legalized cannabis and data security create a multi-front battle that can be incredibly challenging from a legal and technological perspective.

No longer operating in the margins, the highly profitable, and highly regulated, legalized cannabis industry has ably, as well as nimbly, pushed its sales through to mainstream business. Total legal sales of cannabis in the U.S.

In the humid rooms of industrial-sized greenhouses on the outskirts of Geneva live hundreds of hemp plants of more than 60 varieties, a large part of Cornell University’s hemp breeding and genetics program.

At Surge Laboratory, a short walk from the greenhouses, doctoral student Jacob Toth preps several test tubes for analysis. Their orange-hued broth contains genes responsible for making cannabinoids, the 100-plus chemicals found in the cannabis plant.

US scientists face numerous barriers to studying health effects of cannabis

Researchers in the US who want to investigate the medical benefits and risks of cannabis are frustrated. They would like to evaluate the wide array of cannabis products sold in states where cannabis is legal, but federal law prohibits them from doing so because cannabis is still illegal at the federal level.

When quality deserves repeating.

The global cannabis industry is big business and growing fast, expected to reach $100 billion in 2026, a tenfold increase in less than a decade. North America is the dominant market, where almost a dozen more states are considering legalizing cannabis this year.

There are hints that cannabis delivery using mainstream widespread delivery services could happen someday in the same way that alcohol is delivered.

It’s hard to say where we are in the COVID-19 pandemic right now, as infections and deaths continue to rise. But there have been movements in the cannabis industry that are changing the way the industry operates amid the pandemic that may stay post-pandemic.

FSD Pharma has received FDA permission to design and submit an application for a new trial using a synthetic cannabinoid-based drug in the treatment of COVID-19.

Philadelphia, Pennsylvania-based cannabis company FSD Pharma has been granted permission by the Food and Drug Administration to submit an Investigational New Drug Application for a clinical trial using a synthetic cannabinoid drug called ultramicronized palmitoylethanolamide (micro PEA) to treat COVID-19.

A national cannabis trade group is publicly calling for the federal Drug Enforcement Administration (DEA) to keep its hands off of medical marijuana research. Doctors and public health officials—not law enforcement—should be in charge of regulating clinical cannabis research, they say.

Social distancing edicts and general consumer anxiety are changing the way consumers obtain their cannabis supplies.

Online ordering platforms are now the retail destinations of choice for individuals who can legally purchase cannabis supplies, whether for medical or recreational uses.

Ecommerce Technology Responds Amid Crisis

The Covid-19 pandemic has been accompanied by widespread business closures. Retailers who remain open did so with an “essential services” designation, signifying their capacity to deliver indispensable goods and services.